Sisram Medical Announces NMPA Acceptance of Profhilo Registration Application for Facial Indication
Advancing Commercialization Preparations to Expand Injectables Presence in China HONG KONG, Oct. 20, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"),...
Sisram Medical Announces Share Repurchase Plan for Up to 1% of Issued Shares
Reinforcing Confidence in Long-Term Growth and Commitment to Shareholder Returns HONG KONG, Oct. 8, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"),...
Sisram Medical Bolsters EBD and Injectables in Thailand to Unlock APAC Growth
With advancing EBD rollout and steady injectables expansion, integrated treatment protocols deliver unique competitive edges for high-quality regional growth HONG KONG, June 22, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram",...
Sisram Medical Reports Solid Growth in 2025
Solid growth driven by strong performance in international markets, with the injectables business accelerating rapidly DAXXIFY shows promising results from initial commercialization in China, with expansion plans underway HONG KONG, March 23, 2026...
Alma Expands Injectables Presence in APAC with Profhilo® Launch in Thailand
CAESAREA, Israel, Dec. 12, 2024 /PRNewswire/ -- Alma Lasers, a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, announced today the opening of its new subsidiary in Thailand, alongside the launch of...